-
1
-
-
76449087003
-
Mutant prevention concentration of tigecycline for carbapenem-susceptible and -resistant Acinetobacter baumannii
-
Cui JC, Liu YN, Chen LA. Mutant prevention concentration of tigecycline for carbapenem-susceptible and -resistant Acinetobacter baumannii. J Antibiot 2010; 63: 29-31.
-
(2010)
J Antibiot
, vol.63
, pp. 29-31
-
-
Cui, J.C.1
Liu, Y.N.2
Chen, L.A.3
-
2
-
-
84864379255
-
In vivo emergence of tigecycline resistance in multidrug-resistant Klebsiella pneumoniae and Escherichia coli
-
Spanu T, Angelis GD, Cipriani M et al. In vivo emergence of tigecycline resistance in multidrug-resistant Klebsiella pneumoniae and Escherichia coli. Antimicrob Agents Chemother 2012; 56: 4516-8.
-
(2012)
Antimicrob Agents Chemother
, vol.56
, pp. 4516-4518
-
-
Spanu, T.1
Angelis, G.D.2
Cipriani, M.3
-
3
-
-
68949110351
-
Efflux-mediated drug resistance in bacteria: an update
-
Li XZ, Nikaido H. Efflux-mediated drug resistance in bacteria: an update. Drugs 2009; 69: 1555-623.
-
(2009)
Drugs
, vol.69
, pp. 1555-1623
-
-
Li, X.Z.1
Nikaido, H.2
-
4
-
-
84891742685
-
Performance Standards for Antimicrobial Susceptibility Testing: Twenty-third Informational Supplement M100-S23
-
CLSI, Wayne, PA, USA
-
Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Twenty-third Informational Supplement M100-S23. CLSI, Wayne, PA, USA, 2013.
-
(2013)
-
-
-
5
-
-
33746616007
-
Tigecycline: a critical analysis
-
Stein GE, Craig WA. Tigecycline: a critical analysis. Clin Infect Dis 2006; 43: 518-24.
-
(2006)
Clin Infect Dis
, vol.43
, pp. 518-524
-
-
Stein, G.E.1
Craig, W.A.2
-
6
-
-
4344572020
-
Expression of the RNDtype efflux pump AdeABC in Acinetobacter baumannii is regulated by the AdeRS two-component system
-
Marchand I, Damier-Piolle L, Courvalin P et al. Expression of the RNDtype efflux pump AdeABC in Acinetobacter baumannii is regulated by the AdeRS two-component system. Antimicrob Agents Chemother 2004; 48: 3298-304.
-
(2004)
Antimicrob Agents Chemother
, vol.48
, pp. 3298-3304
-
-
Marchand, I.1
Damier-Piolle, L.2
Courvalin, P.3
-
7
-
-
79958023983
-
Genetic regulation of the ramA locus and its expression in clinical isolates of Klebsiella pneumoniae
-
Rosenblum R, Khan E, Gonzalez G et al. Genetic regulation of the ramA locus and its expression in clinical isolates of Klebsiella pneumoniae. Int J Antimicrob Agents 2011; 38: 39-45.
-
(2011)
Int J Antimicrob Agents
, vol.38
, pp. 39-45
-
-
Rosenblum, R.1
Khan, E.2
Gonzalez, G.3
-
8
-
-
50949127977
-
Real-time PCR and statistical analyses of acrAB and ramA expression in clinical isolates of Klebsiella pneumoniae
-
Ruzin A, Immermann FW, Bradford PA. Real-time PCR and statistical analyses of acrAB and ramA expression in clinical isolates of Klebsiella pneumoniae. Antimicrob Agents Chemother 2008; 52: 3430-2.
-
(2008)
Antimicrob Agents Chemother
, vol.52
, pp. 3430-3432
-
-
Ruzin, A.1
Immermann, F.W.2
Bradford, P.A.3
-
9
-
-
84922425503
-
Selection and characterisation of finafloxacin, ciprofloxacin and levofloxacin resistant mutants of Escherichia coli
-
Abstracts of the Forty-eighth Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington, DC, American Society for Microbiology, Washington, DC, USA. Abstract F1-2043
-
Leow P, Stubbings W, Labischinski H. Selection and characterisation of finafloxacin, ciprofloxacin and levofloxacin resistant mutants of Escherichia coli. In: Abstracts of the Forty-eighth Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington, DC, 2008. Abstract F1-2043, p. 306. American Society for Microbiology, Washington, DC, USA.
-
(2008)
, pp. 306
-
-
Leow, P.1
Stubbings, W.2
Labischinski, H.3
-
10
-
-
77954040312
-
Guideline: appropriate use of tigecycline
-
Brink AJ, Bizos D, Boffard KD et al. Guideline: appropriate use of tigecycline. S Afr Med J 2010; 100: 388-94.
-
(2010)
S Afr Med J
, vol.100
, pp. 388-394
-
-
Brink, A.J.1
Bizos, D.2
Boffard, K.D.3
|